Literature DB >> 5751875

Natural antibodies to procaine amide.

A S Russell, M Ziff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5751875      PMCID: PMC1579007     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  36 in total

1.  CANINE SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  R M LEWIS; R SCHWARTZ; W B HENRY
Journal:  Blood       Date:  1965-02       Impact factor: 22.113

2.  FINDINGS SUGGESTIVE OF SYSTEMIC LUPUS ERYTHEMATOSUS IN SUBJECTS ON CHRONIC ANTICONVULSANT THERAPY.

Authors:  K R WILSKE; I E SHALIT; R F WILLKENS; J L DECKER
Journal:  Arthritis Rheum       Date:  1965-04

3.  Lupus erythematosus disseminatus after administration of mesantoin; report of two cases.

Authors:  T LINDQVIST
Journal:  Acta Med Scand       Date:  1957-08-13

4.  Rheumatic and febrile syndrome during prolonged hydralazine treatment.

Authors:  H P DUSTAN; R D TAYLOR; A C CORCORAN
Journal:  J Am Med Assoc       Date:  1954-01-02

5.  Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects.

Authors:  J D MORROW; H A SCHROEDER; H M PERRY
Journal:  Circulation       Date:  1953-12       Impact factor: 29.690

6.  Severe reactions to long-acting sulfonamides. Erythema multiforme exudativum and lupus erythematosus following administration of sulfamethoxypyridazine and sulfadimethoxine.

Authors:  M L RALLISON; J O'BRIEN; R A GOOD
Journal:  Pediatrics       Date:  1961-12       Impact factor: 7.124

7.  Lupus-like syndrome induced by procainamide.

Authors:  A M Fakhro; R F Ritchie; B Lown
Journal:  Am J Cardiol       Date:  1967-09       Impact factor: 2.778

8.  Case report: lupus-like syndrome with positive Hargrave phenomenon induced by pronestyl therapy: analysis of the test.

Authors:  A G Carabia; T G Fortney
Journal:  J Tenn Med Assoc       Date:  1965-09

9.  Procainamide hydrochloride and lupus erythematosus.

Authors:  R Paine
Journal:  JAMA       Date:  1965-10-04       Impact factor: 56.272

10.  The nature of the alpha-methyldopa red-cell antibody.

Authors:  A F LoBuglio; J H Jandl
Journal:  N Engl J Med       Date:  1967-03-23       Impact factor: 91.245

View more
  6 in total

1.  Procainamide-induced systemic lupus erythematosus.

Authors:  P J Sheldon; W R Williams
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

2.  Lupus-like syndrome, with persistent immunological abnormalities, related to procainamide therapy.

Authors:  T P Anastassiades; J A Miliiken
Journal:  Can Med Assoc J       Date:  1972-08-19       Impact factor: 8.262

3.  Antibodies to nucleoprotein and to hydrazide-altered soluble nucleoprotein in tuberculous patients receiving isoniazid.

Authors:  D Alarcón-Segovia; E Fishbein; V M Betancourt
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

4.  Occurrence, immunoglobulin pattern and specificity of antinuclear antibodies in sera of procaine amide treated patients.

Authors:  A Klajman; N Camin-Belsky; A Kimchi; S Ben-Efraim
Journal:  Clin Exp Immunol       Date:  1970-11       Impact factor: 4.330

5.  Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies.

Authors:  R A Asherson; J Zulman; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

6.  Systemic lupus erythematosus syndrome induced by practolol.

Authors:  E B Raftery; A M Denman
Journal:  Br Med J       Date:  1973-05-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.